Dr. Marco Rozas-Serri is a veterinarian (DVM) with an MSc in Aquatic Animal Pathology and a PhD in Veterinary Sciences from Universidad Austral de Chile. He is the founder of Pathovet Labs, an aquatic animal health diagnostics and bioservices company based in Puerto Montt, Chile, with operations in Brazil and across Latin America. His career spans the Chilean salmon industry's technological institute (INTESAL), and two biotechnology start-ups focused on point-of-care molecular diagnostics and AI-based disease detection. He has authored over 40 peer-reviewed publications on the pathogenesis, immunology, diagnosis, and epidemiology of Piscirickettsia salmonis, Piscine orthoreovirus, amoebic gill disease, and emerging bacterial pathogens of Nile tilapia, and holds three patents in aquaculture diagnostics. He serves as Review Editor for Frontiers in Immunology, Editor for Frontiers in Animal Science, and was Guest Executive Editor of a Special Issue on fish vaccines in Fish and Shellfish Immunology. He is a member of WAS, EAFP, and ISFSI, and a guest lecturer in fish pathology and immunology at Universidad Austral de Chile.